Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Comparison of Boric Acid Versus Terconazole in Treatment of Recurrent Vulvovaginal Candidiasis

NCT04208555 is registered in ClinicalTrials.gov with Hatem AbuHashim as lead sponsor.

NCT NCT04208555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04208555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Comparison of Boric Acid Versus Terconazole in Treatment of Recurrent Vulvovaginal Candidiasis
Lead sponsor
Hatem AbuHashim
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2020
Completion date
May 31, 2021
Enrollment
76 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal candidiasis